Home > PE Ratio > ERIS LIFESCIENCES

ERIS LIFESCIENCES
PE (Price/Earnings) Ratio

The Current P/E Ratio of ERIS LIFESCIENCES is 29.14.

Share Price ₹1,361.1Jun 05,2026
Market Cap ₹18,864.2 Cr
Earnings-TTM₹647.4 CrTTM-Consolidated Results
Price/Earnings29.14xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for ERIS LIFESCIENCES
Please provide your vote to see the results
ERIS LIFESCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of ERIS LIFESCIENCES

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of ERIS LIFESCIENCES is calculated as :

Current Market Cap [ ₹18,864.2 Cr] as on Jun 05,2026

(/) Earnings [ ₹647.4 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 29.14x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for ERIS LIFESCIENCES , the investors are currently willing to pay 29.14 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ERIS LIFESCIENCES !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of ERIS LIFESCIENCES over the last five years.

Historical PE (Price/Earnings) ratio chart of ERIS LIFESCIENCES


PE Ratio Performance Analysis for ERIS LIFESCIENCES

- ERIS LIFESCIENCES 's latest p/e ratio is 29.14x.

- ERIS LIFESCIENCES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 30.11x.

- ERIS LIFESCIENCES 's operated at median p/e ratio of 23.11x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, ERIS LIFESCIENCES 's p/e ratio peaked in Mar2025 at 54.83x.

- ERIS LIFESCIENCES 's p/e ratio hit its five-year low in Mar2023 of 20.36x.


How does ERIS LIFESCIENCES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
ERIS LIFESCIENCES 647.4129.1418,864.2
SUN PHARMACEUTICAL INDUSTRIES LTD11,564.5037.00427,933.0
DIVIS LABORATORIES LTD2,568.0068.47175,833.0
TORRENT PHARMACEUTICALS LTD2,138.0069.95149,549.0
CIPLA LTD3,869.7929.24113,155.0
DR REDDYS LABORATORIES LTD4,144.2025.74106,652.0
MANKIND PHARMA LTD1,926.4150.0996,492.8
LUPIN LTD5,355.4719.36103,705.0
ZYDUS LIFESCIENCES LTD5,026.4021.80109,569.0
AUROBINDO PHARMA LTD3,501.4524.0384,151.9
LAURUS LABS LTD889.8587.8578,174.1

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ERIS LIFESCIENCES 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 19.36x
Max industry PE 87.85x
Median industry PE 29.24x
Average industry PE 42.06x



You may also like the below Video Courses